effects of igf-1 lr3 Unlocking the Power LR3: The Ultimate Guide to Growth and Rec Late-life targeting of the IGF-1

The PPAR agonist gemfibrozil was assessed in AD (NCT02045056), but the results remain unreported

A phase 2 trial of R1507, a monoclonal antibody to the insulin-like growth factor-1 receptor (IGF-1R), in patients with recurrent or refractory rhabdomyosarcoma, osteosarcoma, synovial sarcoma, and other soft tissue sarcomas: results of a Sarcoma Alliance for Research Through Collaboration study

10.1038/ncb1337 Nat

Such dysregulation has been linked to myriad pathologies, underscoring the clinical significance of maintaining ER redox homeostasis

Effects of selective serotonin-reuptake inhibitors (ssris) in jeg-3 and hipec cell models of the extravillous trophoblast